DK148022C - Fremgangsmaade til fremstilling af alfa-formen af krystallinsk natrium-o-formyl-cefamandol - Google Patents

Fremgangsmaade til fremstilling af alfa-formen af krystallinsk natrium-o-formyl-cefamandol

Info

Publication number
DK148022C
DK148022C DK150676A DK150676A DK148022C DK 148022 C DK148022 C DK 148022C DK 150676 A DK150676 A DK 150676A DK 150676 A DK150676 A DK 150676A DK 148022 C DK148022 C DK 148022C
Authority
DK
Denmark
Prior art keywords
cefamandol
formyl
preparing
procedure
crystalline sodium
Prior art date
Application number
DK150676A
Other languages
Danish (da)
English (en)
Other versions
DK150676A (da
DK148022B (da
Inventor
Kuo Shang Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK150676A publication Critical patent/DK150676A/da
Publication of DK148022B publication Critical patent/DK148022B/da
Application granted granted Critical
Publication of DK148022C publication Critical patent/DK148022C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK150676A 1975-04-11 1976-03-31 Fremgangsmaade til fremstilling af alfa-formen af krystallinsk natrium-o-formyl-cefamandol DK148022C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/567,324 US4006138A (en) 1975-04-11 1975-04-11 Crystalline form of sodium O-formylcefamandole
US56732475 1975-04-11

Publications (3)

Publication Number Publication Date
DK150676A DK150676A (da) 1976-10-12
DK148022B DK148022B (da) 1985-02-04
DK148022C true DK148022C (da) 1985-07-22

Family

ID=24266692

Family Applications (1)

Application Number Title Priority Date Filing Date
DK150676A DK148022C (da) 1975-04-11 1976-03-31 Fremgangsmaade til fremstilling af alfa-formen af krystallinsk natrium-o-formyl-cefamandol

Country Status (31)

Country Link
US (1) US4006138A (fi)
JP (1) JPS51123812A (fi)
AR (1) AR210880A1 (fi)
AT (1) AT343806B (fi)
AU (1) AU500013B2 (fi)
BE (1) BE840179A (fi)
CA (1) CA1045114A (fi)
CH (1) CH621554A5 (fi)
CS (1) CS191970B2 (fi)
DD (1) DD125950A5 (fi)
DE (1) DE2614669C2 (fi)
DK (1) DK148022C (fi)
ES (1) ES446907A1 (fi)
FI (1) FI65069C (fi)
FR (1) FR2306698A1 (fi)
GB (1) GB1546898A (fi)
GR (1) GR59912B (fi)
HU (1) HU175592B (fi)
IL (1) IL49100A (fi)
LU (1) LU74740A1 (fi)
MX (1) MX3687E (fi)
NL (1) NL184258C (fi)
NO (1) NO151748C (fi)
OA (1) OA05290A (fi)
PL (1) PL104803B1 (fi)
PT (1) PT64917B (fi)
RO (1) RO68501A (fi)
SE (1) SE435290B (fi)
SU (1) SU668608A3 (fi)
YU (1) YU40643B (fi)
ZA (1) ZA761103B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7503274L (sv) * 1974-04-11 1975-10-13 Ciba Geigy Ag Cefalosporin
US4085277A (en) * 1975-01-30 1978-04-18 Fujisawa Pharmaceutical Co., Ltd. 7(2-Phenyl or thienyl-2-isonicotinoyloxyacetamido)-3-(1-methyl-1-H tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid
FR2400519A1 (fr) * 1977-08-17 1979-03-16 Roussel Uclaf Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4946838A (en) * 1981-07-13 1990-08-07 E. R. Squibb & Sons, Inc. Crystalline anhydrous aztreonam
EP0432297A1 (en) * 1989-12-13 1991-06-19 Technologitschen Kombinat Sa Promischlena Mikrobiologia A method for the preparation of the sodium salt of O-formyl cefamandole
US5492903A (en) * 1990-06-19 1996-02-20 Takeda Chemical Industries Ltd. Crystalline esters of (+)-(5R, 6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]he
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
WO2013057196A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
CN104530086B (zh) * 2014-12-16 2015-12-09 天津大学 头孢孟多酯钠化合物的新晶型及其结晶制备方法
CN105037392A (zh) * 2015-08-13 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种杀菌药物头孢孟多酯钠化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887551A (en) * 1964-11-04 1975-06-03 Glaxo Lab Ltd Crystalline forms of cephaloridine
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
NL184258B (nl) 1989-01-02
HU175592B (hu) 1980-09-28
AR210880A1 (es) 1977-09-30
DE2614669A1 (de) 1976-10-21
FR2306698A1 (fr) 1976-11-05
BE840179A (fr) 1976-09-30
GB1546898A (en) 1979-05-31
AT343806B (de) 1978-06-26
NO151748B (no) 1985-02-18
NO761017L (fi) 1976-10-12
US4006138A (en) 1977-02-01
ZA761103B (en) 1977-10-26
ATA258476A (de) 1977-10-15
JPS51123812A (en) 1976-10-28
CS191970B2 (en) 1979-07-31
DK150676A (da) 1976-10-12
CA1045114A (en) 1978-12-26
YU40643B (en) 1986-04-30
SE435290B (sv) 1984-09-17
MX3687E (es) 1981-04-29
PL104803B1 (pl) 1979-09-29
NL7603660A (nl) 1976-10-13
FI760788A (fi) 1976-10-12
PT64917A (en) 1976-04-01
ES446907A1 (es) 1977-09-16
SU668608A3 (ru) 1979-06-15
FR2306698B1 (fi) 1979-10-05
IL49100A0 (en) 1976-04-30
GR59912B (en) 1978-03-20
SE7602565L (sv) 1976-10-12
CH621554A5 (fi) 1981-02-13
LU74740A1 (fi) 1976-11-11
OA05290A (fr) 1981-02-28
PT64917B (en) 1977-08-24
NL184258C (nl) 1989-06-01
YU79276A (en) 1982-10-31
AU1143576A (en) 1977-09-01
FI65069B (fi) 1983-11-30
FI65069C (fi) 1984-03-12
IL49100A (en) 1979-03-12
DK148022B (da) 1985-02-04
DE2614669C2 (de) 1984-09-27
NO151748C (no) 1985-06-05
RO68501A (ro) 1981-04-30
DD125950A5 (fi) 1977-06-01
AU500013B2 (en) 1979-05-10
JPS6110474B2 (fi) 1986-03-29

Similar Documents

Publication Publication Date Title
DK424476A (da) Fremgangsmade til fremstilling af svovlholdige organosiliciumforbindelser
DK49676A (da) Fremgangsmade til fremstilling af hypolipidemiske midler
DK144298C (da) Fremgangsmaade til fremstilling af alkyl-tert-butylethere
DK149642C (da) Praeparat til fremstilling af 99mteknetiumradiodiagnostika
DK593975A (da) Fremgangsmade til fremstilling af substituerede perhalogenalkylamidiner
DK456376A (da) Fremgangsmade til fremstilling af l-arginin-saltet af pgf2alfa
DK107876A (da) Fremgangsmade til fremstilling af thiocarbamider
DK148022C (da) Fremgangsmaade til fremstilling af alfa-formen af krystallinsk natrium-o-formyl-cefamandol
DK535476A (da) Fremgangsmade til fremstilling af 7-methoxycephalosporiner
DK141849C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK259475A (da) Fremgangsmade til fremstilling af heterocycliske forbindelser
DK399976A (da) Fremgangsmade til fremstilling af aralkylamider
DK415576A (da) Fremgangsmade til fremstilling af krystallinsk dipilocarpiniumpamoat
DK522075A (da) Fremgangsmade til fremstilling af hidtil ukendte heterocykliske forbindelser
DK484676A (da) Fremgangsmade til fremstilling af aroyl-phenyliden- eller aroyl-phenylnaphthalenforbindelser
DK137539C (da) Fremgangsmaade til fremstilling af 11beta-fluor-4-androsten-3-oner
DK401476A (da) Fremgangsmade til fremstilling af benzocycloheptapyridinforbindelser
DK420375A (da) Fremgangsmade til fremstilling af heterocycliske forbindelser
DK141584C (da) Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere
DK526676A (da) Fremgangsmade til fremstilling af 4-chlor-2-butynyl-m-chlorcarbanilat
DK424676A (da) Fremgangsmade til fremstilling af 2-alkylindan
DK480676A (da) Fremgangsmade til fremstilling af s-alkylphosphordihalogeniddithioater
DK136774B (da) Fremgangsmade til fremstilling af halogenholdige tertiere phosphinoxider
DK233375A (da) Fremgangsmade til fremstilling af substituerede phenylmercapto-benzimidazoler
DK46476A (da) Fremgangsmade til fremstilling af 5-nitrothiazolylimidazolidiner

Legal Events

Date Code Title Description
PBP Patent lapsed
PUP Patent expired